Literature DB >> 33466523

Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.

Alicia Otero1, Marina Betancor1, Hasier Eraña2,3, Natalia Fernández Borges3, José J Lucas4,5, Juan José Badiola1, Joaquín Castilla3,6, Rosa Bolea1.   

Abstract

Prion diseases are a group of neurodegenerative disorders that can be spontaneous, familial or acquired by infection. The conversion of the prion protein PrPC to its abnormal and misfolded isoform PrPSc is the main event in the pathogenesis of prion diseases of all origins. In spontaneous prion diseases, the mechanisms that trigger the formation of PrPSc in the central nervous system remain unknown. Several reports have demonstrated that the accumulation of PrPSc can induce endoplasmic reticulum (ER) stress and proteasome impairment from the early stages of the prion disease. Both mechanisms lead to an increment of PrP aggregates in the secretory pathway, which could explain the pathogenesis of spontaneous prion diseases. Here, we investigate the role of ER stress and proteasome impairment during prion disorders in a murine model of spontaneous prion disease (TgVole) co-expressing the UbG76V-GFP reporter, which allows measuring the proteasome activity in vivo. Spontaneously prion-affected mice showed a significantly higher accumulation of the PKR-like ER kinase (PERK), the ER chaperone binding immunoglobulin protein (BiP/Grp78), the ER protein disulfide isomerase (PDI) and the UbG76V-GFP reporter than age-matched controls in certain brain areas. The upregulation of PERK, BiP, PDI and ubiquitin was detected from the preclinical stage of the disease, indicating that ER stress and proteasome impairment begin at early stages of the spontaneous disease. Strong correlations were found between the deposition of these markers and neuropathological markers of prion disease in both preclinical and clinical mice. Our results suggest that both ER stress and proteasome impairment occur during the pathogenesis of spontaneous prion diseases.

Entities:  

Keywords:  ER stress; UPS impairment; endoplasmic reticulum; prions; proteasome

Mesh:

Substances:

Year:  2021        PMID: 33466523      PMCID: PMC7796520          DOI: 10.3390/ijms22010465

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  85 in total

1.  Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway.

Authors:  Sang-Wook Kang; Neena S Rane; Soo Jung Kim; Jennifer L Garrison; Jack Taunton; Ramanujan S Hegde
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

2.  Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.

Authors:  Jinte Middeldorp; Willem Kamphuis; Jacqueline A Sluijs; Dalila Achoui; Cathalijn H C Leenaars; Matthijs G P Feenstra; Paula van Tijn; David F Fischer; Celia Berkers; Huib Ovaa; Roy A Quinlan; Elly M Hol
Journal:  FASEB J       Date:  2009-03-30       Impact factor: 5.191

3.  Relationship between beta-amyloid degradation and the 26S proteasome in neural cells.

Authors:  M Lopez Salon; L Pasquini; M Besio Moreno; J M Pasquini; E Soto
Journal:  Exp Neurol       Date:  2003-04       Impact factor: 5.330

4.  Astrocyte plasticity revealed by adaptations to severe proteotoxic stress.

Authors:  Amanda M Titler; Jessica M Posimo; Rehana K Leak
Journal:  Cell Tissue Res       Date:  2013-02-19       Impact factor: 5.249

5.  Ubiquitin immunocytochemistry in human spongiform encephalopathies.

Authors:  J W Ironside; L McCardle; P A Hayward; J E Bell
Journal:  Neuropathol Appl Neurobiol       Date:  1993-04       Impact factor: 8.090

6.  Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.

Authors:  Claudio Hetz; Milene Russelakis-Carneiro; Kinsey Maundrell; Joaquin Castilla; Claudio Soto
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

7.  Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein.

Authors:  Andrea Orsi; Luana Fioriti; Roberto Chiesa; Roberto Sitia
Journal:  J Biol Chem       Date:  2006-08-14       Impact factor: 5.157

8.  Region-Specific Response of Astrocytes to Prion Infection.

Authors:  Natallia Makarava; Jennifer Chen-Yu Chang; Rajesh Kushwaha; Ilia V Baskakov
Journal:  Front Neurosci       Date:  2019-10-09       Impact factor: 4.677

9.  Selective processing and metabolism of disease-causing mutant prion proteins.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

Review 10.  The unfolded protein response in neurodegenerative diseases: a neuropathological perspective.

Authors:  Wiep Scheper; Jeroen J M Hoozemans
Journal:  Acta Neuropathol       Date:  2015-07-26       Impact factor: 17.088

View more
  4 in total

1.  Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie.

Authors:  Marina Betancor; Sonia Pérez-Lázaro; Alicia Otero; Belén Marín; Inmaculada Martín-Burriel; Kaj Blennow; Juan José Badiola; Henrik Zetterberg; Rosa Bolea
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

2.  Evidence of p75 Neurotrophin Receptor Involvement in the Central Nervous System Pathogenesis of Classical Scrapie in Sheep and a Transgenic Mouse Model.

Authors:  Tomás Barrio; Enric Vidal; Marina Betancor; Alicia Otero; Inmaculada Martín-Burriel; Marta Monzón; Eva Monleón; Martí Pumarola; Juan José Badiola; Rosa Bolea
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

3.  Therapeutic Assay with the Non-toxic C-Terminal Fragment of Tetanus Toxin (TTC) in Transgenic Murine Models of Prion Disease.

Authors:  Rosario Osta; Rosa Bolea; Inmaculada Martín-Burriel; Marina Betancor; Laura Moreno-Martínez; Óscar López-Pérez; Alicia Otero; Adelaida Hernaiz; Tomás Barrio; Juan José Badiola
Journal:  Mol Neurobiol       Date:  2021-07-20       Impact factor: 5.590

Review 4.  Advances in Proteasome Enhancement by Small Molecules.

Authors:  Dare E George; Jetze J Tepe
Journal:  Biomolecules       Date:  2021-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.